These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10985927)

  • 21. Isolation of the bombesin/gastrin-releasing peptide receptor from human small cell lung carcinoma NCI-H345 cells.
    Kane MA; Aguayo SM; Portanova LB; Ross SE; Holley M; Kelley K; Miller YE
    J Biol Chem; 1991 May; 266(15):9486-93. PubMed ID: 1851748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide hormones and lung cancer.
    Moody TW
    Panminerva Med; 2006 Mar; 48(1):19-26. PubMed ID: 16633328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion.
    Heuser M; Schlott T; Schally AV; Kahler E; Schliephake R; Laabs SO; Hemmerlein B
    J Urol; 2005 Jun; 173(6):2154-9. PubMed ID: 15879878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
    Maina T; Nock BA; Zhang H; Nikolopoulou A; Waser B; Reubi JC; Maecke HR
    J Nucl Med; 2005 May; 46(5):823-30. PubMed ID: 15872357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meal pattern analysis in rats reveals partial agonist activity of the bombesin receptor antagonist BW2258U89.
    Kirkham TC; Gibbs J; Smith GP; Geary N
    Pharmacol Biochem Behav; 1995 Sep; 52(1):101-6. PubMed ID: 7501650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
    Fleischmann A; Waser B; Reubi JC
    Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bombesin activates MAP kinase in non-small cell lung cancer cells.
    Koh SW; Leyton J; Moody TW
    Peptides; 1999; 20(1):121-6. PubMed ID: 10098632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
    Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
    Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation.
    Moody TW; Nakagawa T; Kang Y; Jakowlew S; Chan D; Jensen RT
    J Mol Neurosci; 2006; 28(3):231-8. PubMed ID: 16691010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells.
    Moody TW; Chiles J; Casibang M; Moody E; Chan D; Davis TP
    Peptides; 2001 Jan; 22(1):109-15. PubMed ID: 11179604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
    Lantry LE; Cappelletti E; Maddalena ME; Fox JS; Feng W; Chen J; Thomas R; Eaton SM; Bogdan NJ; Arunachalam T; Reubi JC; Raju N; Metcalfe EC; Lattuada L; Linder KE; Swenson RE; Tweedle MF; Nunn AD
    J Nucl Med; 2006 Jul; 47(7):1144-52. PubMed ID: 16818949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2-independent induction of apoptosis by neuropeptide receptor antagonist in human small cell lung carcinoma cells.
    Matsumoto Y; Kawatani M; Simizu S; Tanaka T; Takada M; Imoto M
    Anticancer Res; 2000; 20(5A):3123-9. PubMed ID: 11062732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist-dependent immobilization of chimeric bombesin/GRP receptors: dependence on c-Src activity and dissociation from internalization.
    Young SH; Walsh JH; Rozengurt E; Slice LW
    Exp Cell Res; 2001 Jul; 267(1):37-44. PubMed ID: 11412036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2).
    Darker JG; Brough SJ; Heath J; Smart D
    J Pept Sci; 2001 Nov; 7(11):598-605. PubMed ID: 11763364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two novel bombesin-like neuropeptides from the skin secretion of
    Zhang L; Chen C; Zou W; Chen X; Zhou M; Ma C; Xi X; Chen T; Shaw C; Liu M; Wang L
    Front Mol Biosci; 2022; 9():953974. PubMed ID: 36250016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury.
    Shirey KA; Blanco JCG; Vogel SN
    Front Immunol; 2021; 12():705080. PubMed ID: 34282358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolism of BW2258U89, a GRP receptor antagonist.
    Marquez C; Treston A; Moody E; Jakowlew S; Moody TW
    Neuropeptides; 2000 Apr; 34(2):108-15. PubMed ID: 10985927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
    Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
    Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
    Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J
    Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.